Viking Share Price

Viking Share Price

NASDAQ: VKTX | Mid Cap | Healthcare
$25.84
-$0.35 (-1.34%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Viking Stock Performance

Open
$26.23
Prev. Close
$26.19
Circuit Range
N/A
Day Range
$25.58 - $26.72
Year Range
$23.89 - $43.04
Volume
1,11,907
Average Traded
$25.99

Viking Share Price Today

As of 20 November 2026, Viking Therapeutics, Inc.'s share price is $25.84. The stock opened at $26.23, compared to its previous close of $26.19. During today's trading session, Viking Therapeutics, Inc.'s share price traded between $25.58 and $26.72, with an average price of $26.15. Over the past 52 weeks, the stock has recorded a high of $43.04 and a low of $23.89. In terms of performance, Viking Therapeutics, Inc.'s share price has declined by 21.01% over the last six months and is down 29.80% on a year-on-year basis.

Viking Share Price Chart

Line chart of the Viking price trend over the selected period. The price fell overall, ranging from 25.58 to 26.72, ending at 25.84.
$25.58$26.72
L
Show Current Price
H

Viking Stock Fundamentals & Key Indicators

Market Cap
$2.91B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.92
Revenue (TTM)
$0.00
Return On Equity (TTM)
-106.56%
Profit Margin
N/A
Debt to Equity
0.43
Quarterly Earnings Growth YoY
-16.19%

Viking Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$157.66-$158.33-$128.02-$183.19
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-0.42%19.14%-43.09%

Viking Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$68.87-$85.90-$109.96-$359.64
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-24.73%-28.01%-227.06%

Viking Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.131.111.271.49
Current Assets715.6907.22367.23167.04
Total Assets715.73908.32368.49168.53
Non Current Liabilities0.00.630.941.26
Current Liabilities76.6727.4119.1421.95
Total Liabilities76.6728.0420.0723.21
Shareholders' Equity639.06880.28348.42145.32

Viking Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-278.69-87.79-73.38-48.4
Investing341.39-553.37-179.0954.75
Financing76.44612.46271.384.16

About Viking

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Viking Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$27.25
$25.82
-5.51%
Oct 2026
$31.95
$27.32
-16.27%
Sep 2026
$33.08
$32.63
-3.76%
Aug 2026
$31.43
$33.91
+6.75%
Jul 2026
$39.44
$31.76
-18.62%
Jun 2026
$32.22
$39.02
+19.29%
May 2026
$31.31
$32.72
+5.09%
Apr 2026
$32.80
$31.13
-4.33%
Mar 2026
$33.15
$32.54
-3.98%
Feb 2026
$28.65
$33.89
+16.64%
Jan 2026
$35.53
$29.05
-17.39%
Dec 2025
$36.14
$35.17
-4.46%

Viking Share Price FAQs